Back to News
Market Impact: 0.2
Ride Therapeutics Announces up to US$7.3 Million Investment from the Cystic Fibrosis Foundation to Advance Next-Generation Genetic Medicines
Source: Business Wire
Healthcare & BiotechPrivate Markets & VentureTechnology & Innovation
Ride Therapeutics announced an investment from the Cystic Fibrosis Foundation to advance next-generation genetic medicines for cystic fibrosis. The announcement signals external validation and additional funding support for the company’s genetic-medicine development efforts, though no investment amount, clinical data, or development milestones were disclosed.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.35
More News
- Here’s the ‘core economic flaw’ in the AI bull case as stock and bond trades unravel, according to a top economist
- Biotech stocks are surging. How investors can play the new drug innovation boom
- Ukraine says Starlink and Starshield high speed restrictions have been lifted
- Goldman says these top tech stocks have plenty of upside ahead of earnings
- Ukraine says Starlink restored as attacks continue in Russia and Ukraine
- Starlink seems to be working normally again in Ukraine